• ABOUT DRY EYE
  • Symptoms, Causes, and Diagnosis of Dry Eye
  • Treatments for Dry Eye
    • Artificial Tears
    • Prescription Options
    • Other Patient Options
• ABOUT LACRISERT^®
  • How LACRISERT^® Works
  • The Benefits of LACRISERT^®
  • Writing LACRISERT^®
  • How Patients Use LACRISERT^®
  • LACRISERT^® Efficacy Data
  • Patient Testimonials
• RESOURCES FOR YOU + YOUR PATIENTS
  • LACRISERT^® Sample Request
  • Customizable Tip Sheet
  • Aton Patient Savings Program
  • Aton PatientCARE^SM Program
  • Learn More About LACRISERT^®
  • Valuable Links
  • Presentations
• FAQs

Do Your Patients Suffer From Dry Eye?

LACRISERT^®: All-day relief in a single daily dose^*

• Significant improvement in subjective symptoms, objective signs, and activities of daily living requiring high visual acuity^1,2†
• Dissolves quickly and comfortably in the eye to begin all-day relief—like a slow-release artificial tear (AT)^2,3
• No preservatives to cause irritation or damage, even with long-term use^3,4
• Simple and easy placement^3,4
• Preferred by nearly 4 in 5 patients over ATs²

Click any of the links above for more information about Dry Eye and get your patients started on LACRISERT^® today.

LACRISERT^® is indicated in patients with moderate to severe Dry Eye syndromes, including keratoconjunctivitis sicca. LACRISERT^® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT^® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.

Important Safety Information
Do not use LACRISERT^® if you are allergic to hydroxypropyl cellulose. Instructions for inserting and removing LACRISERT^® should be carefully followed. If improperly placed, LACRISERT^® may result in a scratch to the cornea of your eye. Because LACRISERT^® may cause temporary blurred vision, please use caution when driving or operating machinery. Rubbing the eye(s) containing LACRISERT^® should be avoided. You should always discuss this safety information with your doctor. The following adverse reactions have been reported but were in most instances mild and temporary: temporary blurring of vision, eye discomfort or irritation, matting or stickiness of eyelashes, increased sensitivity to light, eyelid swelling, and eye redness. Talk to your doctor if you have side effects that bother you or that do not go away. You are encouraged to report side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

*Some patients may require twice-daily use for optimal results.³

References: 1. Koffler BH; for the LAC-07-01 Study Group. Lacrisert (hydroxypropyl cellulose ophthalmic inserts) significantly improves symptoms of dry eye syndrome (DES) and patient quality of life. Poster presented at: Association for Research in Vision and Ophthalmology (ARVO) 2009 Annual Meeting; May 3-7, 2009; Orlando, Florida. 2. Katz JI, Kaufman HE, Breslin C, Katz IM. Slow-release artificial tears and the treatment of keratitis sicca. Ophthalmology. 1978;85(8):787-793. 3. Lacrisert [package insert]. Lawrenceville, NJ: Aton Pharma, Inc.; 2007. 4. Hill JC. Slow-release artificial tear inserts in the treatment of dry eyes in patients with rheumatoid arthritis. Br J Ophthalmol. 1989;73(2):151-154.

†Multicenter, 2-visit, 4-week, single-arm study conducted in moderate to severe Dry Eye patients who had previously been using ATs (N=520). Results are based on 418 patients who completed the study.